The National Cancer Institute experience with early and late effects of combined modality therapy in small cell lung cancer.
Johnson
B E
BE
NCI-Navy Medical Oncology Branch, Bethesda, Md.
Glatstein
E
E
Ihde
D C
DC
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D009316:National Institutes of Health (U.S.); D011832:Radiation Injuries; D013997:Time Factors; D014481:United States